Overall, the women who developed breast cancer had lower baseline OPG serum levels (mean 90.59 pg/ml; range 4.2–205.7 pg/ml) compared to women who did not develop breast cancer (mean 117.9 pg/ml; range 7.4–547.7 pg/ml). Here, TNFRSF11B is linked to breast cancer.